Follow
Ciurea Adrian
Ciurea Adrian
Unknown affiliation
Verified email at ciurea.ch
Title
Cited by
Cited by
Year
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
D Van Der Heijde, S Ramiro, R Landewé, X Baraliakos, F Van den Bosch, ...
Annals of the rheumatic diseases 76 (6), 978-991, 2017
13012017
B cell depletion may be more effective than switching to an alternative anti–tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti–tumor …
A Finckh, A Ciurea, L Brulhart, D Kyburz, B Möller, S Dehler, S Revaz, ...
Arthritis & rheumatism 56 (5), 1417-1423, 2007
3072007
Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections
L Hunziker, M Recher, AJ Macpherson, A Ciurea, S Freigang, ...
Nature immunology 4 (4), 343-349, 2003
2312003
Comparison of drug retention rates and causes of drug discontinuation between anti–tumor necrosis factor agents in rheumatoid arthritis
SMD Pan, S Dehler, A Ciurea, HR Ziswiler, C Gabay, A Finckh
Arthritis Care & Research: Official Journal of the American College of …, 2009
2052009
TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort
C Molnar, A Scherer, X Baraliakos, M de Hooge, R Micheroli, P Exer, ...
Annals of the rheumatic diseases 77 (1), 63-69, 2018
1992018
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of …
A Finckh, A Ciurea, L Brulhart, B Möller, UA Walker, D Courvoisier, ...
Annals of the rheumatic diseases 69 (2), 387-393, 2010
1842010
Viral persistence in vivo through selection of neutralizing antibody-escape variants
A Ciurea, P Klenerman, L Hunziker, E Horvath, BM Senn, AF Ochsenbein, ...
Proceedings of the National Academy of Sciences 97 (6), 2749-2754, 2000
1702000
Delays in assessment of patients with rheumatoid arthritis: variations across Europe
K Raza, R Stack, K Kumar, A Filer, J Detert, H Bastian, GR Burmester, ...
Annals of the rheumatic diseases 70 (10), 1822-1825, 2011
1662011
Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort
A Ciurea, A Scherer, P Exer, J Bernhard, J Dudler, B Beyeler, R Kissling, ...
Arthritis & Rheumatism 65 (12), 3096-3106, 2013
1592013
Tolerance and effectiveness of anti–tumor necrosis factor α therapies in elderly patients with rheumatoid arthritis: A population‐based cohort study
S Genevay, A Finckh, A Ciurea, AM Chamot, D Kyburz, C Gabay, ...
Arthritis Care & Research 57 (4), 679-685, 2007
1362007
Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice
A Ciurea, P Klenerman, L Hunziker, E Horvath, B Odermatt, ...
Proceedings of the National Academy of Sciences 96 (21), 11964-11969, 1999
1231999
Impairment of Cd4+ T Cell Responses during Chronic Virus Infection Prevents Neutralizing Antibody Responses against Virus Escape Mutants
A Ciurea, L Hunziker, P Klenerman, H Hengartner, RM Zinkernagel
The Journal of experimental medicine 193 (3), 297-306, 2001
1212001
Neutralizing antiviral antibody responses
RM Zinkernagel, A Lamarre, A Ciurea, L Hunziker, AF Ochsenbein, ...
Academic Press 79, 1-53, 2001
1062001
18F-fluoride PET/CT for detection of sacroiliitis in ankylosing spondylitis
K Strobel, DR Fischer, G Tamborrini, D Kyburz, KDM Stumpe, ...
European journal of nuclear medicine and molecular imaging 37 (9), 1760-1765, 2010
962010
A comparison of T cell memory against the same antigen induced by virus versus intracellular bacteria
AF Ochsenbein, U Karrer, P Klenerman, A Althage, A Ciurea, H Shen, ...
Proceedings of the National Academy of Sciences 96 (16), 9293-9298, 1999
891999
CD4+ T-cell–epitope escape mutant virus selected in vivo
A Ciurea, L Hunziker, M Martinic, A Oxenius, H Hengartner, ...
Nature medicine 7 (7), 795-800, 2001
842001
Correlation of T cell independence of antibody responses with antigen dose reaching secondary lymphoid organs: implications for splenectomized patients and vaccine design
AF Ochsenbein, DD Pinschewer, B Odermatt, A Ciurea, H Hengartner, ...
The Journal of Immunology 164 (12), 6296-6302, 2000
772000
Effect of cardiovascular training on fitness and perceived disease activity in people with ankylosing spondylitis
K Niedermann, E Sidelnikov, C Muggli, H Dagfinrud, M Hermann, ...
Arthritis care & research 65 (11), 1844-1852, 2013
742013
Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis
R Micheroli, M Hebeisen, LM Wildi, P Exer, G Tamborrini, J Bernhard, ...
Arthritis research & therapy 19 (1), 1-8, 2017
602017
Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patients
A Finckh, J Dudler, F Wermelinger, A Ciurea, D Kyburz, C Gabay, S Bas
Joint Bone Spine 77 (4), 313-318, 2010
582010
The system can't perform the operation now. Try again later.
Articles 1–20